Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about Novo Nordisk A/S

Recent news which mentions Novo Nordisk A/S

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Novo Nordisk CEO to step down as competition weighs on Wegovy maker's share price
Tags Breaking News: Europe Novo Nordisk A/S Pharmaceuticals
From CNBC.com News
Denmark's economy is booming on drug exports — Trump's tariffs threat won't slow it down
Tags Novo Nordisk A/S GSK plc Breaking News: Politics
From CNBC.com News
Why Americans pay so much more for prescription drugs
Tags Drug Retail LILLY DRN Politics
From CNBC.com News
Healthy Returns: Novo Nordisk’s Wegovy deal with CVS won't derail Eli Lilly's obesity market dominance
Tags Novo Nordisk A/S Health care industry Biotech and Pharmaceuticals
From CNBC.com News
Novo Nordisk cuts 2025 guidance on weaker-than-expected Wegovy sales, posts first-quarter profit beat
Tags AstraZeneca PLC Biotechnology Novo Nordisk A/S
From CNBC.com News
How much a $1,000 investment in Hims & Hers at its IPO would be worth now
Tags Make It Hims & Hers Health Inc Make It: Next Gen Investing
From CNBC.com News
Hims & Hers brings former Amazon executive into C-suite
Tags Health & Science Health care industry Internet
From CNBC.com News
Cramer's week ahead: Earnings from Disney, Palantir and Uber
Tags U/S/ Markets Business CVS Health Corp
From CNBC.com News
Inside the deal: Roche and Zealand Pharma's $5.3 billion obesity drug gambit
Tags LILLY DRN Mergers Roche Holding AG
From CNBC.com News
CVS to boost access to Novo Nordisk's weight loss treatment Wegovy for patients on its drug plans
Tags Health & Science Biotech and Pharmaceuticals Companies
From CNBC.com News
Novo Nordisk opens weight loss drug Wegovy to Hims & Hers, Ro and Life MD telehealth
Tags Breaking News: Business Business News Pharmaceuticals
From CNBC.com News
Novo Nordisk scores major legal win that bars many compounded versions of Wegovy, Ozempic
Tags Breaking News: Business LILLY DRN Business News
From CNBC.com News
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
Tags UnitedHealth Group Inc Bristol/Myers Squibb Co Novo Nordisk A/S
From CNBC.com News
5 European stocks to watch this earnings season as Trump's tariffs hit
Tickers OIL
Tags Oil Business AP Moeller / Maersk A/S
From CNBC.com News
Eli Lilly's weight loss pill succeeds in first late-stage trial on diabetes patients
Tags Biotech and Pharmaceuticals Health & Science AstraZeneca PLC
From CNBC.com News
CNBC Daily Open: Consumers are worried over the economy. The White House insists it’ll be fine
Tags Market Outlook Daily Open World Markets
From CNBC.com News
Pfizer scraps daily weight loss pill after liver injury in one patient
Tags Business US: News Companies
From CNBC.com News
Autos, pharma, luxury and more: The global sectors soaring after Trump's tariffs walkback
Tags Consumer Goods Politics Autos
From CNBC.com News
Trump drops Biden's proposal for Medicare to cover obesity drugs like Wegovy and Zepbound
Tags Companies US: News Business
From CNBC.com News
The biggest winners and losers in Europe as Trump announces sweeping tariffs
Tags Kering SA U/S/ Economy HSBC Holdings PLC
From CNBC.com News
Pharma tariff relief likely short-lived with sector-specific duties on the horizon
Tags Bayer AG Roche Holding AG Biotechnology
From CNBC.com News
Novo Nordisk's diabetes pill slashes risk of cardiovascular complications by 14% after four years
Tags Business News LILLY DRN Breaking News: Business
From CNBC.com News
Novo Nordisk defends disappointing next-gen obesity drug: 'It will be an important product'
Tags Biotech and Pharmaceuticals Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Novo Nordisk says copycat compounders are hurting Wegovy sales, may take legal action
Tags LILLY DRN Novo Nordisk A/S Biotechnology
From CNBC.com News
CNBC Daily Open: Consumers and CFOs alike are expecting a recession in the U.S.
Tags Tesla Inc Daily Open World Markets
From CNBC.com News
CNBC Daily Open: Fears of a U.S. recession intensify among consumers and CFOs
Tags Markets Microstrategy Inc SAP AG
From CNBC.com News
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
Tags LILLY DRN Healthy Returns Social issues
From CNBC.com News
Software giant SAP becomes Europe's most valuable firm amid German stock market boom
Tags LVMH Moet Hennessy Louis Vuitton SE Europe Markets Markets
From CNBC.com News
Eli Lilly will soon release key data on its weight loss pill. Here's why it could be a game-changer
Tags Companies Roche Holding AG Business
From CNBC.com News
Novo Nordisk's next-gen obesity drug CagriSema had investors excited. Now they're not so sure
Tags Biotech and Pharmaceuticals Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.